Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,400
Closed -$3K 2462
2025
Q2
$3K Hold
7,400
﹤0.01% 1930
2025
Q1
$3K Hold
7,400
﹤0.01% 1327
2024
Q4
$5K Hold
7,400
﹤0.01% 901
2024
Q3
$6K Hold
7,400
﹤0.01% 858
2024
Q2
$5K Hold
7,400
﹤0.01% 871
2024
Q1
$10K Hold
7,400
﹤0.01% 834
2023
Q4
$4K Hold
7,400
﹤0.01% 959
2023
Q3
$6K Hold
7,400
﹤0.01% 886
2023
Q2
$5K Hold
7,400
﹤0.01% 898
2023
Q1
$6K Hold
7,400
﹤0.01% 874
2022
Q4
$7K Hold
7,400
﹤0.01% 815
2022
Q3
$16K Hold
7,400
﹤0.01% 685
2022
Q2
$26K Buy
7,400
+2,300
+45% +$8.59K ﹤0.01% 647
2022
Q1
$26K Buy
+5,100
New +$25.8K ﹤0.01% 663
2021
Q2
Sell
-5,345
Closed -$32K 848
2021
Q1
$32K Buy
+5,345
New +$41.1K ﹤0.01% 535
2020
Q4
Sell
-2,000
Closed -$13K 647
2020
Q3
$13K Buy
+2,000
New +$17.8K ﹤0.01% 492

Other funds holding VXRT

Hantz Financial Services's VXRT Position: Q3 2025 in Review

Hantz Financial Services sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 7,400 shares — an estimated $3K sold.

Hantz Financial Services first reported a position in VXRT in Q3 2020 and held it in 16 quarters. The position peaked at $32K in Q1 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Hantz Financial Services reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Hantz Financial Services sold 7,400 Vaxart shares in Q3 2025, an estimated $3K.
  • Hantz Financial Services first reported a position in Vaxart in Q3 2020 and held it in 16 quarters.
  • Hantz Financial Services's Vaxart position peaked at $32K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Hantz Financial Services's 13F filing for Q3 2025, filed 5 Nov 2025.